Jeff Chapman

Jeff Chapman is currently an advisor at GMJ Technologies. Prior to that, they were with Sciex as Senior Director of the CE Business Unit from January 2014 to August 2018. Jeff was responsible for transitioning the Capillary Electrophoresis (CE) Business from Beckman Coulter to AB Sciex, where they combined CE with the micro, nano and chip LC products of Eksigent to form a new MicroScale Bioseparations Business. Jeff also led the CE Business Unit within this organization, including reagent manufacturing - a global team focused on the development, marketing, sales and support of CE.

Before Sciex, Jeff was with Beckman Coulter as Director of Scientific Alliances from January 2012 to December 2013. In this role they led the development of key opinion leader networks for Beckman Coulter Life Sciences. Jeff also created expert channels to capture voice of customer input and collaborated through scientific studies to build strategic advantage. In addition, they enhanced brand awareness through scientific marketing and developed strategy for the future development and planning for analytical products.

Prior to their role as Director of Scientific Alliances, Jeff Chapman was Director of Global Marketing for Beckman Coulter Life Sciences from May 2011 to October 2012.

Jeff Chapman has a post-graduate degree in immunology and neuroimmunology from the University of Calgary. Jeff also has a degree in biochemistry from the University of Saskatchewan, where they graduated cum laude.